Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Heatwurx Inc. (PCSA : NSDQ)

• Company Description    Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States. Number of Employees: 12

• Price / Volume Information    Yesterday's Closing Price: $2.65 Daily Weekly Monthly 20 Day Moving Average: 53,742 shares Shares Outstanding: 2.75 (millions) Market Capitalization: $7.29 (millions) Beta: 1.01 52 Week High: $14.00 52 Week Low: $1.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -11.37% -15.70% 12 Week 18.83% 9.86% Year To Date -7.99% -18.12%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 601 21ST STREET SUITE 300 - VERO BEACH,FL 32960 USA ph: 772-453-2899 fax: 443-288-4420 ir@processapharma.com http://www.processapharmaceuticals.com

• General Corporate Information    Officers George Ng - Chief Executive Officer Russell Skibsted - Chief Financial Officer Khoso Baluch - Director James Neal - Director Geraldine Pannu - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 74275C403 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 2.75 Most Recent Split Date: 12.00 (0.04:1) Beta: 1.01 Market Capitalization: $7.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-3.75 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.87 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 82.80% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -281.31 12/31/25 - -257.81 09/30/25 - -301.42 ROA 03/31/26 - -200.80 12/31/25 - -191.10 09/30/25 - -217.32 Current Ratio 03/31/26 - 0.98 12/31/25 - 2.54 09/30/25 - 3.76 Quick Ratio 03/31/26 - 0.98 12/31/25 - 2.54 09/30/25 - 3.76 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - 0.92 12/31/25 - 2.46 09/30/25 - 2.90 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©